Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

OBJECTIVE: To further evaluate the safety and efficacy of the Control-IQ closed-loop control (CLC) system in children with type 1 diabetes. RESEARCH DESIGN AND METHODS: After a 16-week randomized clinical trial (RCT) comparing CLC with sensor-augmented pump (SAP) therapy in 101 children 6–13 years o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Main Authors: Kanapka, Lauren G., Wadwa, R. Paul, Breton, Marc D., Ruedy, Katrina J., Ekhlaspour, Laya, Forlenza, Gregory P., Cengiz, Eda, Schoelwer, Melissa J., Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J., Weinzimer, Stuart A., DeBoer, Mark D., Buckingham, Bruce A., Oliveri, Mary, Kollman, Craig, Dokken, Betsy B., Cherñavvsky, Daniel, Beck, Roy W.
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2021
Assuntos:
Emerging Technologies: Data Systems and Devices
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7818334/
https://ncbi.nlm.nih.gov/pubmed/33355258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1729
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares